Author

Junyong Zou

Observed name: Zou, Junyong

Institution: Ningbo No. 2 Hospital

Observed institutions: Tongji University, Ningbo No. 2 Hospital, University of Chinese Academy of Sciences

ORCID: 0000-0001-5307-2647

Observed ORCID: 0000-0001-5307-2647

OpenAlex ID: A5075831744

Oxidative Stress, Endothelial Dysfunction, and N -Acetylcysteine in Type 2 Diabetes Mellitus

2024 · Xin Li, Junyong Zou, et al. · Antioxidants and Redox Signaling · 52

Ageing as key factor for distant metastasis patterns and prognosis in patients with extensive-stage Small Cell Lung Cancer

2021 · Junyong Zou, Shijie Guo, et al. · Journal of Cancer · 19

Comprehensive Analysis of Circular RNA Expression Profiles in Gefitinib-Resistant Lung Adenocarcinoma Patients

2022 · Junyong Zou, Huiyin Lan, et al. · Technology in Cancer Research & Treatment · 5

Up-regulating methylation of CAP1 promoter can promote apoptosis and inhibit migration and invasion of lung adenocarcinoma cells

2025 · Guoshu Li, Yunlu Gu, et al. · European journal of medical research · 1

Immune-related cardiotoxicities predict immune checkpoint inhibitors treatment for advanced non-small cell lung cancer: a retrospective multi-center study

2025 · Hengxing Sun, Yini Huang, et al. · Journal of Thoracic Disease

Abnormal hypo-methylation of CAP1 (adenylate cyclase associated protein 1) gene enhances biological characteristics of lung adenocarcinoma cells

2023 · Guoshu Li, Shuanshuan Xie, et al. · Research Square

Author response for "Comprehensive Analysis of Circular RNA Expression Profiles in Gefitinib-Resistant Lung Adenocarcinoma Patients"

2022 · Junyong Zou, Huiyin Lan, et al.

Works count: 9

Citation count: 77

H-index: 3

I10-index: 2